Interstitial Lung Disease With Statin-associated Necrotizing Autoimmune Myopathy Responding to Rituximab

Other users also viewed these articles

Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough? Ivan Castellví, Silvia Vidal, Claudia Valenzuela

10.1016/j.arbres.2021.08.016

Pulmonary Hypertension in Interstitial Lung Disease Bruno Guedes Baldi, Rogério Souza

10.1016/j.arbres.2022.02.002

Post-TB Lung Disease: Where are we to Respond to This Priority? Denise Rossato Silva, Emanuele Pontali, Yousra Kherabi, Lia D’Ambrosio, Rosella Centis, Giovanni Battista Migliori

10.1016/j.arbres.2025.03.001